The Drug Regulatory Authority of Pakistan (Drap) has approved the N-CovKit diagnostic kits that have been developed by scientists at the National University of Science and Technology (Nust) after its trial was successfully completed.

Nust successfully performed lab trials of N-CovKit on 330 blinded samples. These indigenously established assays are robust, sensitive to the target and would soon be available in the market at a lower price compared to imported ones.

Federal Minister for Science and Technology Chaudhry Fawad Hussain also confirmed the news and extended his felicitations to both the leadership of Nust and the scientists.

Read the full story here.

Opinion

Editorial

Exit strategy
Updated 18 Mar, 2026

Exit strategy

MOST members of the international community, particularly states in the greater Middle East, are gravely concerned...
Unsafe trains
18 Mar, 2026

Unsafe trains

SUNDAY’S accident involving the Shalimar Express has once again brought into sharp focus the deep structural and...
Disappointment in Dhaka
18 Mar, 2026

Disappointment in Dhaka

FOR a side looking for lift-off after a disappointing T20 World Cup, it was despair for Shaheen Shah Afridi’s ...
Missing in action
17 Mar, 2026

Missing in action

NOT exactly known for playing a proactive role in protecting the interests of Muslim nations and populations...
Risk to stability
Updated 17 Mar, 2026

Risk to stability

THE risks to Pakistan’s fragile economic recovery from the US-Israel war on Iran cannot be dismissed. Yet the...
Enrolment push
17 Mar, 2026

Enrolment push

THE federal government has embarked upon the welcome initiative to enrol 25,000 out-of-school children in Islamabad...